Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
Preßler H, Machule ML, Ufer F, Bünger I, Li LY, Buchholz E, Werner C, Beraha E, Wagner F, Metz M, Burock S, Bruckert L, Franke C, Wilck N, Krüger A, Reshetnik A, Eckardt KU, Endres M, Prüss H. Preßler H, et al. Among authors: beraha e. Trials. 2024 Mar 7;25(1):172. doi: 10.1186/s13063-024-07982-5. Trials. 2024. PMID: 38454468 Free PMC article.
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.
de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, Leggio L, Agabio R. de Beaurepaire R, et al. Among authors: beraha em. Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708. eCollection 2018. Front Psychiatry. 2019. PMID: 30662411 Free PMC article. Review.
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.
Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtmann M, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L. Agabio R, et al. Among authors: beraha em. Lancet Psychiatry. 2018 Dec;5(12):957-960. doi: 10.1016/S2215-0366(18)30303-1. Epub 2018 Nov 6. Lancet Psychiatry. 2018. PMID: 30413394 Free article. No abstract available.
Response to "Baclofen and alcohol use disorders: From miracle to mirage".
Beraha EM, Salemink E, Goudriaan AE, van den Brink W, Wiers RW. Beraha EM, et al. Eur Neuropsychopharmacol. 2017 Jul;27(7):693-694. doi: 10.1016/j.euroneuro.2017.05.002. Epub 2017 May 30. Eur Neuropsychopharmacol. 2017. PMID: 28576349 No abstract available.
Speaking fluently with baclofen?
Beraha E, Bodewits P, van den Brink W, Wiers R. Beraha E, et al. BMJ Case Rep. 2017 May 11;2017:bcr2016218714. doi: 10.1136/bcr-2016-218714. BMJ Case Rep. 2017. PMID: 28495786 Free PMC article.
Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.
Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest DV, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW. Beraha EM, et al. Eur Neuropsychopharmacol. 2016 Dec;26(12):1950-1959. doi: 10.1016/j.euroneuro.2016.10.006. Epub 2016 Nov 11. Eur Neuropsychopharmacol. 2016. PMID: 27842939 Clinical Trial.
11 results